Atlas Trials

Combination of Irinotecan, Oxaliplatin and Cetuximab for Locally Advanced or Metastatic Pancreatic Cancer

Clinical trial NCT00871169 · COMPLETED

Trial details

NCT number
NCT00871169
Sponsor
New Mexico Cancer Research Alliance
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2008-10-01
Primary completion
2015-04-01
Enrollment
61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.